DEXCOM INC. DL-,001/ US2521311074 /
2024-06-17 1:06:20 PM | Chg. +1.32 | Volume | Bid1:06:20 PM | Ask1:06:20 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
107.88EUR | +1.24% | - Turnover: - |
107.88Bid Size: - | 108.46Ask Size: - | 43.07 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.